Scarborough Advisors »

Ligand Pharmaceuticals In shares owned by Scarborough Advisors

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Scarborough Advisors from 13F filings

Historical chart of Scarborough Advisors investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Scarborough Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Scarborough Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $3.8k 33 113.67
2024-06-30 $2.8k 33 84.27
2024-03-31 $2.4k 33 73.09
2023-12-31 $2.4k 33 71.42

More positions owned by Scarborough Advisors

Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust Portfolio S&p500 (SPLG)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Columbia Etf Tr I Resh Enhnc Cor (RECS)
Blackrock Etf Trust Ishares Us Thema (THRO)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ishares Tr Msci Usa Mmentm (MTUM)
Spdr Gold Tr Gold Shs (GLD)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)

View all positions for Scarborough Advisors

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
Macquarie Group
State Street Corporation
Congress Asset Management
Chicago Capital
Stephens Investment Management Group
Massachusetts Financial Services
Dimensional Fund Advisors
Geode Capital Management
FMR
Loomis, Sayles and
Invesco
Ubs Global Asset Management Americas

View all funds holding Ligand Pharmaceuticals In